Synergistic Effects of Melittin and Plasma Treatment: A Promising Approach for Cancer Therapy

Melittin (MEL), a small peptide component of bee venom, has been reported to exhibit anti-cancer effects in vitro and in vivo. However, its clinical applicability is disputed because of its non-specific cytotoxicity and haemolytic activity in high treatment doses. Plasma-treated phosphate buffered s...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaw, Priyanka, Kumar, Naresh, Hammerschmid, Dietmar, Privat-Maldonado, Angela, Dewilde, Sylvia, Bogaerts, Annemie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721819/
https://www.ncbi.nlm.nih.gov/pubmed/31382579
http://dx.doi.org/10.3390/cancers11081109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721819/
https://www.ncbi.nlm.nih.gov/pubmed/31382579
http://dx.doi.org/10.3390/cancers11081109

Ejemplares similares